PA007170: In Vivo Grade Recombinant Anti-HIV V1V2 Loop Glycan Human IgG1 Lambda Monoclonal Antibody
The in vivo grade recombinant anti-HIV V1V2 loop glycan human IgG1 monoclonal antibody (clone of CAP256-VRC26.25) was produced in mammalian cells.
Applications: ELISA, Western blot, immunohistochemistry (IHC), Flow Cytometry (FC), and various in vitro and in vivo functional assays.PA007183: In Vivo Grade Recombinant Anti-HIV V1V2 Loop Glycan Human IgG1 Lambda Monoclonal Antibody
The in vivo grade recombinant anti-HIV V1V2 loop glycan human IgG1 monoclonal antibody (clone of PG9) was produced in mammalian cells.
Applications: ELISA, Western blot, immunohistochemistry (IHC), Flow Cytometry (FC), and various in vitro and in vivo functional assays.PA007177: In Vivo Grade Recombinant Anti-HIV V3 Loop Glycan Human IgG1 Lambda Monoclonal Antibody
The in vivo grade recombinant anti-HIV V3 loop glycan human IgG1 monoclonal antibody (clone of 10-1074) was produced in mammalian cells.
Applications: ELISA, Western blot, immunohistochemistry (IHC), Flow Cytometry (FC), and various in vitro and in vivo functional assays.PA007172: In Vivo Grade Recombinant Anti-HIV V3 Loop Glycan Human IgG1 Lambda Monoclonal Antibody
The in vivo grade recombinant anti-HIV V3 loop glycan human IgG1 monoclonal antibody (clone of PGT121) was produced in mammalian cells.
Applications: ELISA, Western blot, immunohistochemistry (IHC), Flow Cytometry (FC), and various in vitro and in vivo functional assays.- BP000085-CYT-135: Recombinant Human Interferon-alpha 14 (IFNA14) Protein
Source: E. coli-derived.
Purity > 90% as determined by SDS-PAGE. BP000151-CYT-104: Recombinant Human IL-28A, HEK
Source: HEK-derived.
The specific activity was determined by the dose dependent protection of the cytopathic effect on A549 cells (human lung adenocarcinoma epithelial cell line) that were challenged with encephalomyocarditis (EMC) virus and is typically 0.5-5 ug/ml.
Purity: > 95% as obsereved by SDS-PAGE.BP000151-CYT-602: Recombinant Human IL-28A
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP002450-CA25: Recombinant Human Interleukin-28B (IL-28B) Protein
Source: HEK 293-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP002450-CYT-105: Recombinant Human Interleukin-28B (IL-28B) Protein
Source: HEK-derived.
The specific activity was determined by the dose dependent protection of the cytopathic effect on A549 cells (human lung adenocarcinoma epithelial cell line) that were challenged with encephalomyocarditis (EMC) virus and is typically 0.1-1 ng/ml.
Purity: > 95% as obsereved by SDS-PAGE.BP000152-CYT-117: Recombinant Human IL-29, HEK
Source: HEK-derived.
The specific activity was determined by the dose dependent protection of the cytopathic effect on A549 cells (human lung adenocarcinoma epithelial cell line) that were challenged with encephalomyocarditis (EMC) virus and is typically 0.5-5 ug/ml.
Purity: > 95% as obsereved by SDS-PAGE.